In Vitro Safety Study on the Use of Cold Atmospheric Plasma in the Upper Respiratory Tract

URN to cite this document:: urn:nbn:de:bvb:355-epub-591048
DOI to cite this document:: 10.5283/epub.59104

Karrer, Sigrid

; Unger, Petra ; Gruber, Michael

; Gebhardt, Lisa ; Schober, Robert ; Berneburg, Mark

; Bosserhoff, Anja Katrin ; Arndt, Stephanie

License: Creative Commons Attribution 4.0
PDF - Published Version
(5MB)

Date of publication of this fulltext: 05 Sep 2024 09:25

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Cold atmospheric plasma (CAP) devices generate reactive oxygen and nitrogen species, have antimicrobial and antiviral properties, but also affect the molecular and cellular mechanisms of eukaryotic cells. The aim of this study is to investigate CAP treatment in the upper respiratory tract (URT) to reduce the incidence of ventilator-associated bacterial pneumonia (especially ...